These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 20504121
1. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study. Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J. Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121 [Abstract] [Full Text] [Related]
2. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients. Okin PM. J Electrocardiol; 2009 May; 42(6):584-8. PubMed ID: 19631946 [Abstract] [Full Text] [Related]
3. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives. Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO. Ethn Dis; 2005 May; 15(4):578-84. PubMed ID: 16259479 [Abstract] [Full Text] [Related]
4. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations. Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747 [Abstract] [Full Text] [Related]
5. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study]. González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA. Rev Esp Cardiol; 2007 Feb 12; 60(2):148-56. PubMed ID: 17338880 [Abstract] [Full Text] [Related]
6. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB. J Hypertens; 2007 May 12; 25(5):1079-85. PubMed ID: 17414673 [Abstract] [Full Text] [Related]
7. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study. Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K. J Hum Hypertens; 2011 Mar 12; 25(3):178-85. PubMed ID: 20505749 [Abstract] [Full Text] [Related]
8. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review. Bang CN, Devereux RB, Okin PM. J Electrocardiol; 2014 Mar 12; 47(5):630-5. PubMed ID: 25052475 [Abstract] [Full Text] [Related]
9. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements. Sosnowski M, Korzeniowska B, Tendera M. Int J Cardiol; 2006 Jan 26; 106(3):382-9. PubMed ID: 15996771 [Abstract] [Full Text] [Related]
10. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men]. Zeng XZ, Liu DP, He Q, Guo HL, Fang F, Liu DG, Dong R, Zeng HY. Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan 26; 37(1):56-8. PubMed ID: 19671355 [Abstract] [Full Text] [Related]
11. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. Okin PM, Roman MJ, Devereux RB, Kligfield P. J Am Coll Cardiol; 1996 Jan 26; 27(1):124-31. PubMed ID: 8522685 [Abstract] [Full Text] [Related]
12. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study. Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group. Hypertension; 2000 Jan 26; 35(1 Pt 1):13-8. PubMed ID: 10642268 [Abstract] [Full Text] [Related]
13. Sokolow-Lyon voltage criteria in sickle cell patients. Foucan L, Haddad A, Genevier I, Samuel Y, Salmi RL. West Indian Med J; 1999 Sep 26; 48(3):132-6. PubMed ID: 10555459 [Abstract] [Full Text] [Related]
14. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators. JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161 [Abstract] [Full Text] [Related]
15. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients. da Costa W, Riera AR, Costa Fde A, Bombig MT, de Paola AA, Carvalho AC, Fonseca FH, Luna Filho B, Póvoa R. J Electrocardiol; 2008 Nov 17; 41(6):724-9. PubMed ID: 18954613 [Abstract] [Full Text] [Related]
16. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement. Angeli F, Verdecchia P, Angeli E, Poeta F, Sardone M, Bentivoglio M, Prosciutti L, Cocchieri M, Zollino L, Bellomo G, Rondoni F, Garognoli O, Lenti S, Frigerio C, Gattobigio R, Benemio G, Biscottini B, Panciarola R, Buccolieri M, Liberati R, Trottini M, Cipollini F, Gemelli F, Schillaci G, Porcellati C. J Cardiovasc Med (Hagerstown); 2006 Nov 17; 7(11):812-6. PubMed ID: 17060807 [Abstract] [Full Text] [Related]
17. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study. Barrios V, Calderón A, Escobar C, Barrios S, Navarro-Cid J, González-Pedel V, Vegazo O, Fernandez R. J Hypertens; 2007 Sep 17; 25(9):1967-73. PubMed ID: 17762663 [Abstract] [Full Text] [Related]
18. Variability and concordance of Cornell and Sokolow-Lyon electrocardiographic criteria in hypertensive patients. Vinyoles E, Rodriguez-Blanco T, de la Figuera M, Colomé JM, Tafalla M, Calbet N, Fernández-San Martin MI, García-Alonso J, Murillo C, Agudo J. Blood Press; 2012 Dec 17; 21(6):352-9. PubMed ID: 22587668 [Abstract] [Full Text] [Related]
19. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction. Barrabés JA, Figueras J, Cortadellas J, Lidón RM, Ibars S. Am J Cardiol; 2009 Feb 15; 103(4):455-60. PubMed ID: 19195501 [Abstract] [Full Text] [Related]
20. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K. Am J Cardiol; 2011 Aug 15; 108(4):541-7. PubMed ID: 21624542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]